Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (131-140 of 251) with videos related to

Pageof 26
Sort By:
Cancer Communications|January 1, 1989
Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavageR Ganapathi, D Grabowski, J Ford, et al.
Biochemistry|June 4, 1998
Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.
Cancer Research|June 1, 1986
Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitorsY Pommier, D Kerrigan, R E Schwartz, et al.
Cell Proliferation|April 1, 1996
Expression of proliferation-associated nuclear autoantigens, p330d/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometryA Báez, K Torres, E M Tan, et al.
Cancer Research|February 24, 2001
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding siteY Urasaki, G Laco, Y Takebayashi, et al.
The Journal of Biological Chemistry|May 16, 2000
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediateJ Fertala, J R Vance, P Pourquier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cellsP Pourquier, Y Takebayashi, Y Urasaki, et al.
Biochemical Pharmacology|September 1, 1992
Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantroneN Kamath, D Grabowski, J Ford, et al.
Biochemistry|October 15, 1996
DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinataY Pommier, G Kohlhagen, C Bailly, et al.
Carcinogenesis|November 1, 1994
Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitorsP Russo, G Cimoli, M Valenti, et al.
Pageof 26

Showing results (131-140 of 251) with videos related to

Sort By:
Pageof 26
Cancer Communications|January 1, 1989
Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavageR Ganapathi, D Grabowski, J Ford, et al.
Biochemistry|June 4, 1998
Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNAI Chourpa, J F Riou, J M Millot, et al.
Cancer Research|June 1, 1986
Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitorsY Pommier, D Kerrigan, R E Schwartz, et al.
Cell Proliferation|April 1, 1996
Expression of proliferation-associated nuclear autoantigens, p330d/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometryA Báez, K Torres, E M Tan, et al.
Cancer Research|February 24, 2001
Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding siteY Urasaki, G Laco, Y Takebayashi, et al.
The Journal of Biological Chemistry|May 16, 2000
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediateJ Fertala, J R Vance, P Pourquier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cellsP Pourquier, Y Takebayashi, Y Urasaki, et al.
Biochemical Pharmacology|September 1, 1992
Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantroneN Kamath, D Grabowski, J Ford, et al.
Biochemistry|October 15, 1996
DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinataY Pommier, G Kohlhagen, C Bailly, et al.
Carcinogenesis|November 1, 1994
Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitorsP Russo, G Cimoli, M Valenti, et al.
Pageof 26